Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore
ConclusionsWe describe a novel neurological scale that can be used by non-specialists to describe acute neurological changes in children receiving experimental therapy for DIPG. Prospective validation as part of a clinical trial is required.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Tumor | Cancer & Oncology | Chemotherapy | Child Development | Children | Clinical Trials | Disability | Glioma | Headache | Intensive Care | Migraine | Neurology | Nurses | Nursing | Opthalmology | Pediatrics